Presbyterian/St. Luke's Medical Center, Denver Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00114530
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Blood and Marrow Transplant Program, Colorado Blood Cancer Institute, Presbyterian/St. Luke's Medical Center, Denver | Blood and Marrow Transplant Program, Presbyterian/St. Luke's Medical Center, Rocky Mountain Cancer Center